
Tibet Rhodiola Pharmaceutical Holding Co.
SSE:600211.SS
37.13 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 2,806.713 | 3,134.328 | 2,554.609 | 2,138.587 | 1,373.105 | 1,256.022 | 1,027.879 | 915.626 | 796.807 | 1,382.756 | 1,668.036 | 1,402.221 | 1,221.385 | 1,079.038 | 1,110.729 | 1,109.621 | 991.07 | 823.238 | 861.842 | 696.482 | 182.662 | 75.08 | 74.491 | 74.659 | 83.123 | 82.967 | 78.045 | 48.29 | 21.659 |
Cost of Revenue
| 162.297 | 155.085 | 146.694 | 223.218 | 194.965 | 206.643 | 206.373 | 239.58 | 188.576 | 935.465 | 1,328.315 | 1,122.458 | 978.015 | 885.167 | 918.834 | 921.118 | 841.519 | 722.225 | 639.167 | 578.52 | 98.953 | 17.627 | 13.963 | 9.556 | 13.763 | 15.832 | 10.9 | 8.642 | 5.148 |
Gross Profit
| 2,644.417 | 2,979.244 | 2,407.915 | 1,915.368 | 1,178.14 | 1,049.379 | 821.506 | 676.045 | 608.231 | 447.291 | 339.721 | 279.764 | 243.371 | 193.871 | 191.895 | 188.504 | 149.551 | 101.013 | 222.675 | 117.962 | 83.71 | 57.452 | 60.527 | 65.103 | 69.36 | 67.135 | 67.146 | 39.648 | 16.511 |
Gross Profit Ratio
| 0.942 | 0.951 | 0.943 | 0.896 | 0.858 | 0.835 | 0.799 | 0.738 | 0.763 | 0.323 | 0.204 | 0.2 | 0.199 | 0.18 | 0.173 | 0.17 | 0.151 | 0.123 | 0.258 | 0.169 | 0.458 | 0.765 | 0.813 | 0.872 | 0.834 | 0.809 | 0.86 | 0.821 | 0.762 |
Reseach & Development Expenses
| 23.478 | 17.35 | 88.13 | 60.857 | 7.459 | 11.074 | 8.208 | 4.158 | 7.484 | 4.162 | 2.823 | 2.686 | 1.377 | 3.65 | 1.62 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 37.246 | 48.93 | 47.747 | 44.44 | 34.652 | 31.774 | 27.929 | 24.831 | 16.543 | 14.081 | 18.384 | 13.184 | 12.831 | 13.863 | 13.382 | 33.914 | 32.396 | 43.16 | 37.964 | 56.062 | 27.367 | 20.671 | 16.454 | 16.365 | 13.252 | 8.663 | 3.693 | 2.759 | 2.06 |
Selling & Marketing Expenses
| 1,556.624 | 1,746.977 | 1,408.963 | 1,154.912 | 684.555 | 623.038 | 484.29 | 376.867 | 357.124 | 315.529 | 246.249 | 207.409 | 180.708 | 138.036 | 132.299 | 147.189 | 103.903 | 144.134 | 183.773 | 93.686 | 52.864 | 37.705 | 34.238 | 32.504 | 27.507 | 28.288 | 30.52 | 16.517 | 7.888 |
SG&A
| 1,593.87 | 1,881.449 | 1,456.709 | 1,199.352 | 719.208 | 654.812 | 512.22 | 401.698 | 373.667 | 329.61 | 264.633 | 220.593 | 193.54 | 151.9 | 145.681 | 181.103 | 136.298 | 187.295 | 221.737 | 149.748 | 80.231 | 58.376 | 50.692 | 48.869 | 40.759 | 36.951 | 34.212 | 19.276 | 9.947 |
Other Expenses
| -138.842 | 177.762 | 110.874 | 78.761 | -7.394 | 38.571 | -20.054 | 48.124 | 32.503 | -0.189 | 1.317 | 21.464 | 22.527 | 17.515 | 17.653 | 14.856 | 9.893 | 11.365 | 17.571 | 5.91 | 7.917 | 3.306 | 4.56 | 2.456 | 5.216 | 6.039 | 2.396 | 0.752 | -0.248 |
Operating Expenses
| 1,483.966 | 2,076.561 | 1,655.714 | 1,338.971 | 719.273 | 704.457 | 500.374 | 414.601 | 411.304 | 373.604 | 308.223 | 256.98 | 221.145 | 181.564 | 173.177 | 184.647 | 138.48 | 188.841 | 224.291 | 151.305 | 81.252 | 58.557 | 50.814 | 48.97 | 40.856 | 37.147 | 34.401 | 19.312 | 9.983 |
Operating Income
| 1,160.45 | 899.093 | 768.03 | 565.247 | 472.117 | 351.224 | 331.47 | 213.479 | 189.794 | 106.647 | 25.641 | 8.66 | 9.535 | 5.957 | 12.339 | 7.638 | -4.164 | -137.362 | -13.629 | -48.349 | 0.026 | 4.746 | 8.113 | 18.631 | 33.589 | 32.318 | 30.499 | 19.44 | 5.844 |
Operating Income Ratio
| 0.413 | 0.287 | 0.301 | 0.264 | 0.344 | 0.28 | 0.322 | 0.233 | 0.238 | 0.077 | 0.015 | 0.006 | 0.008 | 0.006 | 0.011 | 0.007 | -0.004 | -0.167 | -0.016 | -0.069 | 0 | 0.063 | 0.109 | 0.25 | 0.404 | 0.39 | 0.391 | 0.403 | 0.27 |
Total Other Income Expenses Net
| -8.366 | -0.898 | 0.962 | -300.708 | -1.802 | 1.441 | 0.383 | 48.124 | 32.503 | -0.322 | 0.872 | 21.437 | 22.513 | 17.43 | 17.635 | 14.793 | -5.367 | -41.611 | 16.003 | -9.476 | 6.033 | 0.941 | 2.032 | -0.395 | 0.82 | 5.059 | 1.43 | 0.438 | -0.248 |
Income Before Tax
| 1,152.084 | 898.195 | 463.392 | 254.852 | 470.315 | 352.666 | 244.437 | 261.603 | 222.033 | 106.326 | 26.514 | 30.097 | 32.048 | 23.422 | 29.974 | 22.451 | 5.703 | -129.439 | 2.75 | -42.629 | 6.059 | 5.688 | 10.145 | 18.237 | 35.948 | 37.377 | 31.93 | 19.878 | 5.597 |
Income Before Tax Ratio
| 0.41 | 0.287 | 0.181 | 0.119 | 0.343 | 0.281 | 0.238 | 0.286 | 0.279 | 0.077 | 0.016 | 0.021 | 0.026 | 0.022 | 0.027 | 0.02 | 0.006 | -0.157 | 0.003 | -0.061 | 0.033 | 0.076 | 0.136 | 0.244 | 0.432 | 0.451 | 0.409 | 0.412 | 0.258 |
Income Tax Expense
| 95.009 | 87.95 | 88.115 | 41.824 | 49.653 | 35.296 | 26.35 | 27.312 | 22.636 | 15.588 | 6.305 | 6.135 | 1.546 | 2.335 | 5.793 | 1.607 | -0.155 | 0.784 | 0.295 | 0.229 | 0.063 | 17.197 | 8.213 | 4.496 | 0.222 | 4.302 | -3.212 | -1.21 | -0.684 |
Net Income
| 1,051.288 | 800.914 | 369.84 | 208.938 | 418.096 | 312.321 | 215.606 | 229.646 | 198.289 | 91.636 | 20.98 | 27.153 | 30.53 | 20.514 | 23.557 | 19.087 | 6.486 | -125.269 | 3.077 | -41.324 | 6.081 | 5.775 | 10.198 | 18.299 | 35.722 | 33.075 | 31.93 | 19.878 | 5.597 |
Net Income Ratio
| 0.375 | 0.256 | 0.145 | 0.098 | 0.304 | 0.249 | 0.21 | 0.251 | 0.249 | 0.066 | 0.013 | 0.019 | 0.025 | 0.019 | 0.021 | 0.017 | 0.007 | -0.152 | 0.004 | -0.059 | 0.033 | 0.077 | 0.137 | 0.245 | 0.43 | 0.399 | 0.409 | 0.412 | 0.258 |
EPS
| 3.26 | 2.48 | 1.49 | 0.84 | 1.69 | 1.25 | 0.86 | 0.98 | 0.97 | 0.45 | 0.1 | 0.14 | 0.15 | 0.1 | 0.11 | 0.11 | 0.033 | -0.58 | 0.02 | -0.15 | 0.024 | 0.023 | 0.04 | 0.071 | 0.12 | 0.13 | 0.12 | 0.072 | 0.02 |
EPS Diluted
| 3.26 | 2.48 | 1.49 | 0.84 | 1.69 | 1.25 | 0.86 | 0.98 | 0.97 | 0.45 | 0.1 | 0.14 | 0.15 | 0.1 | 0.11 | 0.11 | 0.033 | -0.58 | 0.02 | -0.15 | 0.024 | 0.023 | 0.04 | 0.071 | 0.12 | 0.13 | 0.12 | 0.072 | 0.02 |
EBITDA
| 1,236.578 | 976.16 | 551.188 | 351.311 | 558.096 | 433.147 | 321.241 | 359.525 | 292.399 | 126.843 | 49.076 | 58.567 | 59.169 | 44.724 | 51.525 | 42.045 | 26.445 | -67.771 | 35.807 | -10.16 | 30.66 | 29.928 | 25.432 | 27.319 | 34.609 | 32.714 | 32.745 | 20.336 | 6.528 |
EBITDA Ratio
| 0.441 | 0.311 | 0.216 | 0.164 | 0.406 | 0.345 | 0.313 | 0.393 | 0.367 | 0.092 | 0.029 | 0.042 | 0.048 | 0.041 | 0.046 | 0.038 | 0.027 | -0.082 | 0.042 | -0.015 | 0.168 | 0.399 | 0.341 | 0.366 | 0.416 | 0.394 | 0.42 | 0.421 | 0.301 |